Edit

Domain Associates

https://www.domainvc.com/

Last activity: 10.11.2023

Tags:MedTechDevelopmentHealthTechProductHardwareBioTechTechnologyDrugDiagnosticsSkin

ABOUT Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on investing in life science companies that advance human health. Domain’s focused network, deep experience, and dependable reputation of this team have made it one of the top private-equity groups participating in healthcare investing. With $2.4 billion of capital under management, Domain invests in three major segments: pharmaceuticals, diagnostics, and medical devices. EXPERIENCE Domain has raised eight funds and has been involved in the formation of more than 250 portfolio companies. The partners of Domain have a total of close to 200 person-years of experience among them in the healthcare and venture capital industries. Representative past investments include Amgen, Amylin Pharmaceuticals, BiPar Sciences, Biosite, Dura Pharmaceuticals and Pharmion. Our companies have created a number of U.S. approved products that have advanced human health. LEADERSHIP We have developed innovative investment models, such as specialty pharma and Japanese in-licensing, which have proven successful and have been widely emulated in the life science industry. We are engaged in new collaborations, including Domain’s investments in Russia and China with Rusnano and Beijing Elite, respectively.

News

460

Portfolio

Mentions

Location: United States, New Jersey

Employees: 11-50

Founded date: 1985

Investment Type: Venture Capital

Investment Stage: Series B; Series C; Series D

Twitter

News 460

Date	Title	Description	_References
01.02.2022	Fractyl Health Publishes Two-Year Durability Data After a Si...	;LEXINGTON, MA., February 1, 2022 - Fractyl Health, an organ-editing metabolic therapeutics company ...	-
21.04.2021	Antios Therapeutics Doses First Patients in SAVE 1, a Phase ...	;MENDHAM, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- Antios Therapeutics, Inc. (“Antios”) today announ...	-
24.02.2020	Antios Therapeutics Announces Notice of Allowance for a U.S....	;ATLANTA, Feb. 24, 2020 /PRNewswire/ -- Antios Therapeutics, Inc. ("Antios"), a clinical-s...	-
09.01.2020	Omniome Closes $60 Million Series C Financing To Advance Nov...	;SAN DIEGO—January 9, 2020 – Omniome, Inc., developer of an innovative DNA sequencing platform capab...	-
12.12.2019	Aspen Neuroscience Launches With $6.5 Million Seed Funding t...	;SAN DIEGO, Dec. 12, 2019 — Aspen Neuroscience, Inc. today announced its launch following a $6.5 mil...	-
09.12.2019	Achillion Reports Positive Data from Phase 2 Study of Danico...	;BLUE BELL, Pa., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a...	-
11.11.2019	Achillion Announces Clearance of Investigational New Drug Ap...	;BLUE BELL, Pa., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a...	-
25.10.2019	Bempedoic Acid Included in Top 10 Medical Innovations for 20...	;ANN ARBOR, Mich., Oct. 25, 2019 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) announced that bempedoic...	-
22.10.2019	Obalon Announces First Patient Treatments at its First Compa...	;SAN DIEGO, CA, October 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a weig...	-
21.10.2019	Veracyte Announces New Data Demonstrating That Envisia Genom...	;SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct. 21, 2019-- Veracyte, Inc. (Nasdaq: VCYT) announc...	-
17.10.2019	Marinus Phase 2 Clinical Data on Ganaxolone in RSE Presented...	;RADNOR, Pa., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marin...	-
16.10.2019	Alexion to Acquire Achillion	;BOSTON & BLUE BELL, Pa.--(BUSINESS WIRE)--Oct. 16, 2019-- Alexion Pharmaceuticals, Inc. (NASDAQ...	-
11.10.2019	FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in...	;Eli Lilly won FDA approval for a migraine drug on Friday, giving the pharmaceutical giant a second ...	-
07.10.2019	Veracyte to Announce New Clinical Data for First Noninvasive...	;SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct. 7, 2019-- Veracyte, Inc. (Nasdaq: VCYT) today an...	-
03.10.2019	Milestone Pharmaceuticals Announces First Patient Enrolled i...	;MONTREAL and CHARLOTTE, N.C., Oct. 3, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: ...	-
10.09.2019	Milestone Pharmaceuticals Announces Appointment of Amit Hasi...	;MONTREAL and CHARLOTTE, N.C., Sept. 10, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq...	-
13.08.2019	Milestone Pharmaceuticals Provides Positive Regulatory Updat...	;MONTREAL and CHARLOTTE, N.C., Aug. 13, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq:...	-
25.06.2019	WindMIL Therapeutics Announces FDA Clearance of Investigatio...	;BALTIMORE, MD AND PHILADELPHIA, PA – June 25, 2019 – WindMIL Therapeutics, a clinical-stage company...	-
14.05.2019	Milestone Pharmaceuticals Announces Full Exercise of Underwr...	;MONTREAL and CHARLOTTE, N.C., May 14, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: ...	-
08.05.2019	Milestone Pharmaceuticals Announces Pricing of Upsized Initi...	;MONTREAL and CHARLOTTE, N.C., May 8, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: M...	-
06.05.2019	Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre...	;SAN FRANCISCO, May 06, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (Nasdaq: ADYX), a clinical-stage bioph...	-
16.04.2019	Milestone Pharmaceuticals Appoints Paul Edick Chairman of it...	;Montreal, QC, CA, and Charlotte, NC, April 16, 2019 – Milestone Pharmaceuticals, a late-stage bioph...	-
04.04.2019	Milestone Pharmaceuticals Appoints Michael Tomsicek to Board...	;Montreal, QC, CA, and Charlotte, NC, April 4, 2019 – Milestone Pharmaceuticals, a late-stage biopha...	-
19.03.2019	Iterum Therapeutics Receives QIDP for Oral and IV Sulopenem ...	;DUBLIN, Ireland and CHICAGO, March 19, 2019 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: IT...	-
18.09.2018	Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials o...	;DUBLIN, Ireland and CHICAGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: IT...	-
17.09.2018	U.S. FDA Clears Sebacia Microparticles for the Treatment of ...	;Duluth, GA – September 17, 2018 – Sebacia, Inc., a privately held, commercial stage dermatology and...	-
09.08.2018	Iterum Initiates SURE 1, a Phase 3 Clinical Trial of Oral Su...	;DUBLIN and CHICAGO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a cli...	-
02.08.2018	Celtaxsys Announces Results of Phase 2 Trial Showing Clinica...	;ATLANTA – August 2, 2018 – Celtaxsys, Inc., a clinical stage pharmaceutical development company foc...	-
04.01.2018	Celtaxsys Secures Private Financing to Advance Acebilustat P...	;Atlanta, GA – (January 4, 2018) – Celtaxsys, Inc., a clinical stage drug development company focuse...	-
24.10.2017	Milestone Pharmaceuticals Appoints Lorenz Muller as Chief Co...	;;CHARLOTTE, N.C., Oct. 24, 2017 /PRNewswire/ -- Milestone Pharmaceuticals USA, Inc., a clinical sta...	-
02.10.2017	Esperion Completes Patient Enrollment in Global Pivotal Phas...	;ANN ARBOR, Mich., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the ...	-
26.09.2017	FierceBiotech's 2017 Fierce 15	;The philosophy of Fierce 15 is a simple one: We want to see the best science combined with the best...	-
21.08.2017	IntegenX Applauds the Passage of the Rapid DNA Act of 2017	;;PLEASANTON, Calif.--(BUSINESS WIRE)--IntegenX Inc., the global market leader for Rapid DNA human i...	-
01.08.2017	Milestone Pharmaceuticals Closes $55 Million Series C Financ...	;;MONTREAL, August 1, 2017 /PRNewswire/ -- Milestone Pharmaceuticals Montreal, Canada, Inc., a clini...	-
25.07.2017	Sebacia grabs $36M to push gold microparticle acne treatment...	;;Sebacia, which already markets its gold-and-silica microparticle acne treatment in Europe, raised ...	-
25.07.2017	Iterum Gains Important Support for Development of Novel Oral...	;;DUBLIN, IRELAND – July 25th, 2017 – Iterum Therapeutics Limited, a clinical-stage pharmaceutical c...	-
29.06.2017	FDA Grants Orphan Drug Designation for Ganaxolone in CDKL5 D...	;RADNOR, Pa., June 29, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a bioph...	-
27.06.2017	Marinus Pharmaceuticals Launches the Ganaxolone Clinical Pro...	;;RADNOR, Pa., June 27, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biop...	-
26.06.2017	Esperion Announces FDA Confirmation of Regulatory Pathway to...	;;Ann Arbor, Mich., -- (Globe Newswire – June 26, 2017) -- Esperion Therapeutics, Inc. (NASDAQ: ESPR...	-
19.05.2017	Iterum Secures $65 Million in Series B Financing	;DUBLIN, IRELAND, and CHICAGO – May 19, 2017 – Iterum Therapeutics Limited, an Irish clinical-stage ...	-
17.05.2017	Syndax Announces Results from Phase 2 ENCORE 601 Trial of En...	;;WALTHAM, Mass., May 17, 2017 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. ("Syndax,"...	-
11.05.2017	Milestone Pharmaceuticals Announces Etripamil Phase 2 Clinic...	;;MONTREAL, May 11, 2017 /PRNewswire/ -- Milestone Pharmaceuticals Montreal, Canada, Inc., a clinica...	-
11.05.2017	FIRST EVER NASAL SPRAY THERAPY SUCCESSFUL IN TREATING RAPID ...	;;CHICAGO, May 11, 2017 – Results of a groundbreaking clinical trial demonstrate the effectiveness o...	-
27.04.2017	ChromaCode Raises $12 Million in Series B for Commercial Lau...	;;CARLSBAD, Calif., April 27, 2017 /PRNewswire/ -- ChromaCode, Inc., a molecular diagnostics company...	-
18.04.2017	MARINUS TO PRESENT GANAXOLONE DATA AT AMERICAN ACADEMY OF NE...	;;RADNOR, PA, April 18, 2017 (Globe Newswire) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biop...	-
12.04.2017	Milestone Pharmaceuticals to Present Etripamil Phase 2 Data ...	;;MONTREAL, April 12, 2017 /PRNewswire/ -- Milestone Pharmaceuticals Montreal, Canada, Inc., a clini...	-
21.03.2017	USPTO Grants Composition of Matter Patent to Achillion for S...	;NEW HAVEN, Conn., March 21, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) ...	-
20.03.2017	Esperion Announces FDA Confirmation Regarding Regulatory Pat...	;;Ann Arbor, Mich., -- (Globe Newswire – March 20, 2017) – Esperion Therapeutics, Inc. (NASDAQ:ESPR)...	-
06.03.2017	Esperion Announces Oral Presentation on Genetic Validation o...	;;ANN ARBOR, Mich., March 06, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), th...	-
01.02.2017	Marinus Appoints Michael R. Dougherty to its Board of Direct...	;;RADNOR, PA, February 1, 2017 (Globe Newswire) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a bi...	-
25.01.2017	Esperion Completes Enrollment of Pivotal Phase 3 Long-Term S...	;;ANN ARBOR, Mich., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the...	-
23.01.2017	MARINUS ANNOUNCES POSITIVE PRELIMINARY DATA FROM CHILDREN WI...	;;RADNOR, PA, January 23, 2017 (Globe Newswire) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), toda...	-
08.01.2017	Esperion Announces Initiation of Three Pivotal Phase 3 Studi...	;;Ann Arbor, Mich., -- (Globe Newswire – January 8, 2017) -- Esperion Therapeutics, Inc. (NASDAQ: ES...	-
05.01.2017	Marinus Provides Business Outlook for 2017	;;RADNOR, PA, January 5, 2017 (Globe Newswire) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a bio...	-
23.12.2016	TWO PEER-REVIEWED PUBLICATIONS HIGHLIGHT CLINICAL UTILITY OF...	;;SALT LAKE CITY, December 19, 2016 – Sera Prognostics, Inc., a women’s healthcare company, today an...	-
01.12.2016	Axial Biotherapeutics Announces the Groundbreaking Discovery...	;;BOSTON, December 1, 2016 – Axial Biotherapeutics today announced that researchers from the Califor...	-
30.11.2016	Axial Biotherapeutics Launches to Treat Patients with CNS Di...	;;BOSTON, November 30, 2016 – Axial Biotherapeutics today announced the launch of the Company with a...	-
28.11.2016	Esperion Therapeutics Announces Publication of Definitive Pa...	;ANN ARBOR, Mich., Nov. 28, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a ph...	-
20.09.2016	Allergan to Acquire Tobira Therapeutics Expanding Global GI ...	;;DUBLIN and SAN FRANCISCO, Sept. 20, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading globa...	-
06.09.2016	ROX Medical Raises $40M Financing	;;SAN CLEMENTE, Calif., Sept. 6, 2016 /PRNewswire/ -- ROX Medical, a privately held clinical-stage m...	-
07.07.2016	GENOMIC HEALTH AND EPIC SCIENCES ANNOUNCE STRATEGIC COLLABOR...	;;REDWOOD CITY AND SAN DIEGO, CA, July 6, 2016;Genomic Health, Inc. (Nasdaq: GHDX) and Epic Sciences...	-
22.06.2016	Marinus Pharmaceuticals Doses First Subject in Phase 1 Clini...	;;RADNOR, Pa., June 22, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biop...	-
06.06.2016	Celator Pharmaceuticals(R) Presented Phase 3 Trial Results i...	;;EWING, N.J., June 6, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today annou...	-
31.05.2016	JAZZ PHARMACEUTICALS AND CELATOR PHARMACEUTICALS ANNOUNCE AG...	;;DUBLIN and EWING, N.J., May 31, 2016 -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Celator Pharma...	-
19.05.2016	Celator Pharmaceuticals® Announces VYXEOS™ Granted Breakthro...	;;EWING, N.J., May 19, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today annou...	-
09.05.2016	Aldeyra Therapeutics Announces Positive Results From Phase I...	;;LEXINGTON, MA -- (Marketwired) -- 05/09/16 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra),...	-
03.05.2016	Achillion Reports First Quarter 2016 Financial Results and P...	;;NEW HAVEN, Conn., May 03, 2016 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) t...	-
21.04.2016	Celator® Pharmaceuticals to Present Phase 3 Data at 2016 Ame...	;;EWING, N.J., April 21, 2016/PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX) today annou...	-
15.04.2016	Marinus Pharmaceuticals Receives FDA Orphan Drug Designation...	;;RADNOR, Pa., April 15, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a bio...	-
11.04.2016	Syndax Announces Entinostat Data to be Presented at the Amer...	;;WALTHAM, Mass., April 11, 2016 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX), a c...	-
31.03.2016	Celator(R) Pharmaceuticals Announces New Data for VYXEOS(TM)...	;;EWING, N.J., March 31, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today ann...	-
31.03.2016	REVA MEDICAL, INC. (ASX: RVA) ("REVA" OR THE "...	;;SAN DIEGO, CALIFORNIA AND SYDNEY, AUSTRALIA (WEDNESDAY, 30 MARCH 2016, AEDT) - REVA MEDICAL, INC. ...	-
21.03.2016	Celator(R) Pharmaceuticals Announces Business Update and Fou...	;;EWING, N.J., March 21, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX), a biopha...	-
16.03.2016	New Data Show That Veracyte’s Afirma® Gene Expression Classi...	;;SOUTH SAN FRANCISCO, Calif., March 16, 2016 --- Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnos...	-
14.03.2016	Celator Announces Phase 3 Trial for VYXEOS™ (CPX-351) in Pat...	;;EWING, N.J., March 14, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today ann...	-
10.03.2016	Landmark Study Published in American Journal of Obstetrics &...	;;SALT LAKE CITY, March 10, 2016 – Sera Prognostics, Inc., a women’s healthcare company, today annou...	-
29.02.2016	Aldeyra Therapeutics Reports Positive Results from Phase IIa...	;;LEXINGTON, Mass., February 29, 2016 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (...	-
23.02.2016	CoLucid Pharmaceuticals Announces Confirmatory Support for N...	;;CAMBRIDGE, Mass., Feb. 23, 2016 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD), a...	-
11.02.2016	Achillion Initiates Phase 1 Study of ACH-4471, First Orally-...	;;NEW HAVEN, Conn., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) ...	-
21.01.2016	INTERNATIONAL STUDY SHOWS 3-YEAR BENEFITS OF GLAUKOS ISTENT®...	;;LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical te...	-
21.01.2016	Five Prime Therapeutics Announces Preliminary Data From the ...	;;SOUTH SAN FRANCISCO, Calif., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasd...	-
20.01.2016	Allan L. Shaw Joins Syndax Pharmaceuticals As Chief Financia...	;;WALTHAM, Mass., Jan. 20, 2016 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical stage bioph...	-
13.01.2016	Esperion Therapeutics Announces Initiation of Phase 3 Clinic...	;;ANN ARBOR, Mich., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a p...	-
12.01.2016	Esperion Therapeutics Announces Initiation of Phase 2 Clinic...	;;ANN ARBOR, Mich., Jan. 12, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a p...	-
11.01.2016	Achaogen Announces Enrollment of First Patient in EPIC, a Ph...	;;SOUTH SAN FRANCISCO, CA, USA I January 11, 2016 I Achaogen, Inc. (AKAO), a clinical-stage biopharm...	-
11.01.2016	Five Prime Therapeutics Provides Update on FP-1039 Clinical ...	;;SOUTH SAN FRANCISCO, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasd...	-
11.01.2016	Celator(R) Pharmaceuticals Announces Participation in Cardif...	;;EWING, N.J., Jan. 11, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX) today annou...	-
07.01.2016	Tobira Therapeutics Announces Initiation of Program to Evalu...	;;SOUTH SAN FRANCISCO, Calif., Jan. 7, 2016 /PRNewswire/ -- Tobira Therapeutics, Inc. (NASDAQ: TBRA)...	-
07.01.2016	Veracyte Announces Expansion to New South San Francisco Faci...	;;SOUTH SAN FRANCISCO, Calif., Jan. 7, 2016 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT), a molecul...	-
05.01.2016	BioNano Genomics Highlights Study Using Next-Generation Mapp...	;;SAN DIEGO, Jan. 05, 2016 (GLOBE NEWSWIRE) -- BioNano Genomics, the leader in physical genome mappi...	-
04.01.2016	Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce C...	;;Darmstadt, Germany, New York, US and Waltham, Mass., US, January 4, 2016 – Merck KGaA, Darmstadt, ...	-
17.12.2015	Navihealth Acquires Rightcare Solutions	;Navihealth Acquires Rightcare Solutions -Company is a Leader in Post-Acute Decision Support and Re...	-
15.12.2015	Alimera Sciences Signs Agreement To Distribute ILUVIEN® In T...	;;ATLANTA, Dec. 15, 2015 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmace...	-
14.12.2015	Veracyte Announces Positive Coverage Policy for the Afirma® ...	;;SOUTH SAN FRANCISCO, Calif., December 14, 2015 --- Veracyte, Inc. (NASDAQ: VCYT), a molecular diag...	-
11.12.2015	Otonomy Announces FDA Approval of OTIPRIO(TM) for the Treatm...	;;SAN DIEGO, Dec. 11, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical comp...	-
08.12.2015	Afferent Pharmaceuticals Advances Novel Molecule, AF-130, to...	;;December 08, 2015 08:00 AM Eastern Standard Time SAN MATEO, Calif.--(BUSINESS WIRE)--Afferent Pha...	-
08.12.2015	Tobira Therapeutics Announces Data Presentations Highlightin...	;;SOUTH SAN FRANCISCO, Calif., Dec. 8, 2015 /PRNewswire/ -- Tobira Therapeutics, Inc. (NASDAQ: TBRA)...	-
07.12.2015	Neothetics Announces Issuance by USPTO of Fourth Patent Dire...	;;SAN DIEGO, Dec. 7, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage speci...	-
06.12.2015	Atara Bio Announces Positive Results From a Phase 2 Clinical...	;;SOUTH SAN FRANCISCO, Calif., Dec. 06, 2015 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq...	-
03.12.2015	Syndax Announces Multiple Data Presentations On Entinostat A...	;;WALTHAM, Mass., Dec. 3, 2015 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical stage biopha...	-
01.12.2015	Syndax Announces Initiation Of Entinostat Clinical Program I...	;;WALTHAM, Mass., Dec. 1, 2015 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical stage biopha...	-

Portfolio 94

Date	Name	Website	Total Raised	Location
01.08.2017	Milestone ...	milestonep...	$190M	Canada, Qu...
25.07.2017	Sebacia	sebacia.co...	$68M	United Sta...
19.05.2017	Iterum The...	iterumtx.c...	$157M	-
28.04.2017	Epic Scien...	epicscienc...	$217M	United Sta...
27.04.2017	ChromaCode...	chromacode...	$88M	-
-	Sequent Me...	sequentmed...	$61.6M	-
-	Adastra Ph...	adastrarx....	-	-
-	Aspen Neur...	aspenneuro...	$264M	United Sta...
-	Goodwell T...	goodwellte...	-	-
-	Obalon The...	obalon.com	$56.5M	United Sta...
-	REVA Medic...	teamreva.c...	$25M	United Sta...
-	Dicerna Ph...	dicerna.co...	$159M	United Sta...
-	Ariosa Dia...	ariosadx.c...	-	-
-	DRI Holdin...	dri.ru.com	-	-
-	Miramar La...	miramarlab...	-	-
-	MicroVenti...	microventi...	-	United Sta...
-	Ocunexus T...	ocunexus.c...	-	-
-	Tobira The...	tobiratx.c...	-	-
-	Achaogen, ...	achaogen.c...	$87.6M	United Sta...
-	Exelixis	exelixis.c...	-	United Sta...
-	Ocera Ther...	ocerainc.c...	-	-
-	VentiRx Ph...	ventirx.co...	-	-
-	Fractyl He...	fractyl.co...	$141M	United Sta...
-	Axial Ther...	axialtx.co...	$37.3M	United Sta...
-	Vanda Phar...	vandapharm...	-	-
-	Volcano Co...	volcanocor...	-	United Sta...
-	Marinus Ph...	marinuspha...	$21M	-
-	Align Tech...	aligntech....	-	United Sta...
-	ProteinSim...	proteinsim...	-	United Sta...
-	OraPharma,...	orapharma....	-	-
-	Evofem Bio...	evofem.com	$160M	United Sta...
-	Aldeyra Th...	aldeyra.co...	-	United Sta...
-	NuVasive	nuvasive.c...	-	United Sta...
-	Zogenix, I...	zogenix.co...	$179M	United Sta...
-	Syndax	syndax.com	$152.6M	-
-	Cartiva, I...	cartiva.ne...	$21.3M	-
-	Bionano Ge...	bionanogen...	$104.5M	United Sta...
-	Antios The...	antiosther...	$196M	South Afri...
-	Singular G...	singularge...	-	United Sta...
-	DIANON Syt...	dianon.com	-	-
-	Omniome	omniome.co...	$120M	United Sta...
-	Esperion I...	esperion.c...	$463M	United Sta...
-	IntegenX I...	integenx.c...	-	United Sta...
-	Veracyte, ...	veracyte.c...	$101M	United Sta...
-	Otonomy, I...	otonomy.co...	$143.9M	United Sta...
-	Adynxx, In...	adynxx.com	$16M	United Sta...
-	ReVision O...	revisionop...	$132M	United Sta...
-	Celator Ph...	celatorpha...	$57.5M	-
-	DiObex, In...	diobex.com	$24M	-
-	colorescie...	colorescie...	$46.5M	United Sta...
-	Truvian He...	truvianhea...	$132.1M	United Sta...
-	Astute Med...	astutemedi...	$109.9M	United Sta...
-	RightCare ...	rightcares...	$10.75M	-
-	aTyr Pharm...	atyrpharma...	$240.5M	United Sta...
-	Orexigen T...	orexigen.c...	$225M	United Sta...
-	Smart Medi...	smartmedsy...	$14.5M	Israel, Ce...
-	Five Prime...	fiveprime....	$1M	United Sta...
-	Clovis Onc...	clovisonco...	$275M	United Sta...
-	Amgen	amgen.com	-	United Sta...
-	VIVUS Inc.	vivus.com	$33.6M	United Sta...
-	Tandem Dia...	tandemdiab...	$52.3M	United Sta...
-	Achillion ...	achillion....	-	United Sta...
-	Evoke Phar...	evokepharm...	-	United Sta...
-	Atara Bio	atarabio.c...	$90.5M	United Sta...
-	NeuroPace	neuropace....	$150.3M	United Sta...
-	CoLucid Ph...	colucid.co...	$44.6M	United Sta...
-	Novadigm T...	novadigm.n...	-	United Sta...
-	SkinMedica	skinmedica...	$11M	United Sta...
-	Xagenic, I...	xagenic.co...	$70.5M	Canada, On...
-	Carticept ...	carticept....	$30M	-
-	GlaukosCor...	glaukos.co...	$59.5M	United Sta...
-	Senomyx, I...	senomyx.co...	-	-
-	Eddingphar...	eddingphar...	$24M	-
-	Zyga Techn...	zyga.com	$10M	United Sta...
-	Alimera Sc...	alimerasci...	-	United Sta...
-	Benvenue M...	benvenueme...	$188M	United Sta...
-	OmniSonics...	omnisonics...	-	-
-	Asmacure, ...	asmacure.c...	-	United Sta...
-	WindMIL Th...	windmiltx....	-	-
-	Afferent P...	afferentph...	$78M	United Kin...
-	Landec Cor...	landec.com	$73.5M	-
-	Kona Medic...	konamedica...	$80M	United Sta...
-	Sera Progn...	seraprogno...	$165.3M	United Sta...
-	Geron Corp...	geron.com	-	-
-	Acureon Ph...	acureonpha...	-	United Sta...
-	Seraphina ...	seraphinat...	$5.5M	United Sta...
-	BioVascula...	biovascula...	-	-
-	Applied Bi...	appliedbio...	-	-
-	Cardiac Sc...	cardiacsci...	-	-
-	GI Dynamic...	gidynamics...	$32.75M	United Sta...
-	LaJolla Ph...	ljpc.com	-	United Sta...
-	Exalys The...	exalystx.c...	-	-
-	Cantex Pha...	cantex.com	-	-
-	Durata The...	duratather...	-	United Sta...

Mentions in press and media 79

Date	Title	Description	Source
18.05.2020	Seraphina Therapeutics Reveals Groundbreaking Fatty Acid Dis...	Seraphina Therapeutics, Inc., announced today its Series A fundraise of $5.5 million, led by Domain ...	vegconomis...
20.11.2019	With echoes of Theranos, Truvian Sciences revives the dream ...	A little over a year after the dissolution of the once high-flying blood testing startup Theranos, a...	techcrunch...
01.08.2017	Tekla Capital Joins $55M Series C for Milestone Pharmaceutic...	Milestone Pharmaceuticals Montreal, Canada, Inc., a clinical stage cardiovascular company, today ann...	citybizlis...
01.08.2017	Domain Associates Joins $55M Series C for Milestone Pharmace...	Milestone Pharmaceuticals Montreal, Canada, Inc., a clinical stage cardiovascular company, today ann...	citybizlis...
25.07.2017	Domain Associates Leads $20M Series D for Sebacia	Sebacia, Inc., a privately held, clinical and commercial stage dermatology and aesthetics company, t...	citybizlis...
21.05.2017	Iterum Raises $65M Series B	Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the developme...	citybizlis...
21.05.2017	Domain Associates Joins $65M Series B for Iterum	Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the developme...	citybizlis...
30.04.2017	Domain Associates Joins $40M Series D for Epic Sciences	Epic Sciences (Epic) announced today that the company has completed a $40 million Series D financing...	citybizlis...
27.04.2017	Domain Associates Joins $12M Series B for ChromaCode	ChromaCode, Inc., a molecular diagnostics company, today announced it has raised $12 million in Seri...	citybizlis...
27.04.2017	NEA Leads $12M Series B for ChromaCode	ChromaCode, Inc., a molecular diagnostics company, today announced it has raised $12 million in Seri...	citybizlis...
09.12.2016	Term Sheet — Friday, December 9	Layoff Watch and Founder-Friendly Boards It’s the kind of thing that stinks to be right about. Earl...	fortune.co...
09.12.2016	Domain Associates Closes Latest Life Sciences Venture Capita...	Domain Associates, a San Diego, CA and Princeton, NJ-based venture capital firm focused on the life ...	finsmes.co...
19.11.2015	Daily funding roundup - November 19, 2015	PresenceLearning raised $25M; UrbanClap scored $25M; Cinematique closed $3.5M funding Touchable vid...	vator.tv/n...
24.10.2015	A look at the underbelly of Theranos, plus 5 must-read stori...	1. Genetic testing turns quick ROI in Aetna wellness program Aetna is crediting genetic testing of ...	medcitynew...
20.10.2015	Watch out, Theranos? Edico Genome CEO backing stealth one-dr...	Given the recent focus on single drop of blood diagnostics, it’s safe to assume this Dx company is f...	medcitynew...
10.07.2015	Xagenic Raises CAD$15M in Funding	Xagenic, a Toronto, Canada-based molecular diagnostics company developing the lab-free Xagenic X1™ p...	finsmes.co...
17.09.2014	RightCare Solutions secures $4 million investment from NewSp...	In addition to Murphy, other members include Dennis Podlesak and Jesse Treu from venture firm Domain...	medcitynew...
04.09.2014	Fractyl Laboratories Secures $40M in Series C Funding	Fractyl Laboratories, a Waltham, Mass.-based developer of a device-based endoscopic procedure to tre...	finsmes.co...
18.06.2014	Benvenue Medical secures $40M Series E to beef up manufactur...	InterWest Partners led the round, and general partner Dr. Gil Kliman was appointed to Benvenue’s boa...	medcitynew...
11.12.2013	Domain VC: Why we’re investing more in molecular diagnostics...	Some firms have pulled back on investing in molecular diagnostics, and Silicon Valley Bank life scie...	medcitynew...
02.12.2013	Xagenic Closes $20M Series B Financing	Xagenic Inc., a Toronto, Canada-based molecular diagnostics company, closed a $20m Series B financin...	finsmes.co...
13.11.2013	Health IT company nets $5M for tool to lower readmissions	Last year, Right Care netted $1.76 million in a series A round. It has done several implementations ...	medcitynew...
04.11.2013	Healthcare startup with noninvasive, one-time wet AMD treatm...	Anti-VEGF therapy proved to be a major breakthrough in treatment for wet AMD. The drugs could halt t...	medcitynew...
04.10.2013	$14M round for ‘cross-kingdom vaccine’ maker will fund trial...	The vaccine contains a recombinant form of Als3, a protein found on the surface of Candida albicans ...	medcitynew...
03.10.2013	NovaDigm Therapeutics Closes $14M Series B Financing	NovaDigm Therapeutics, a Grand Forks, North Dakota-based developer of vaccines for fungal and bacter...	finsmes.co...
29.07.2013	Domain's $760 million co-investment partnership with Rusnano...	PRINCETON, N.J. and SAN DIEGO, July 29, 2013 /PRNewswire/ -- Domain Associates, a leading life sci...	domainvc.c...
29.07.2013	Domain Associates: Fifth Investment With Rusnano From $7...	San Diego-based venture investor Domain Associates is reporting today that a fifth company in its po...	socaltech....
12.06.2013	Domain Associates Promotes Shah To Partner	San Diego-based biotech investment firm Domain Associates announced this morning that it has promote...	socaltech....
25.04.2013	Esperion Therapeutics Raises $33M to Further Clinical Trials	Share Share on Facebook Share on Twitter LinkedIn Email Reprints The Ann Arbor-based biotech compan...	xconomy.co...
25.04.2013	Esperion Therapeutics Completes $33M Financing	Esperion Therapeutics, Inc., a Plymouth, MI-based clinical stage biopharmaceutical company, complete...	finsmes.co...
16.04.2013	Why digital health is no ‘bubble’	Paul Sonnier is Head of Digital Health Strategy at specialty life sciences consulting firm Popper an...	venturebea...
19.12.2012	Biopharma startup raises $51M for therapeutic to treat bleed...	Other treatment programs in its pipeline that will benefit from the new funding include its REG1 ind...	medcitynew...
19.12.2012	Domain Associates, Rusnano Boost Three Firms By $93M ...	San Diego-based venture capital firm Domain Associates and its Russian partner, Rusnano, have put pa...	socaltech....
13.11.2012	Epic Sciences Completes $13M Series B Equity Financing	Epic Sciences, Inc., a San Diego, CA-based biotech company that develops cancer diagnostics, has com...	finsmes.co...
13.11.2012	Cancer diagnostics firm that can enable personalized medicin...	“Epic’s technology has achieved an unprecedented level of sensitivity in detecting circulating tumor...	medcitynew...
11.10.2012	Discharge decision support startup feted by Janssen raises $...	The Fort Washington, Pennsylvania company was co-founded by CEO Eric Heil and Kathy Bowles, a profes...	medcitynew...
03.10.2012	Biotech company developing therapies for macular edema raise...	Solution/Product: The company makes the Iluvien drug delivery system that is implanted at the back o...	medcitynew...
24.05.2012	Cash from innovation challenges will provide pilot testing f...	A readmission risk assessment tool and two diabetes education programs will now be put to the ultima...	medcitynew...
14.05.2012	Health IT tool to reduce hospital readmissions identifies vu...	A healthcare IT program aimed at reducing hospital readmissions by more effectively coordinating vul...	medcitynew...
08.03.2012	Morning Read: Personal genetic map may soon be as cheap as a...	Doctors say that investing time to create videos and blog posts makes for more productive use of fac...	medcitynew...
18.01.2012	Carticept Medical Closes $10M Financing	Carticept Medical, Inc., an Alpharetta, Ga.-based developer of innovative products for the treatment...	finsmes.co...
09.01.2012	Aria Diagnostics Raises Over $50m in Series C Funding	Aria Diagnostics (formerly known as Tandem Diagnostics), a San Jose, Calif.-based molecular diagnost...	finsmes.co...
30.12.2011	Celator Pharmaceuticals raising $5 million for cancer treatm...	The Celator’s approach to cancer treatment is based on a synergistic ratio of drugs to improve tumor...	medcitynew...
15.11.2011	Sera Prognostics Raises $19.3M in Series A Funding	Sera Prognostics Inc., a Salt Lake City, UT–based company that develops tests to diagnose preterm bi...	finsmes.co...
22.02.2011	Early stage biotechs face funding gap as VCs seek surer bets...	Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficient...	medcitynew...
03.06.2010	Apnex taps Boston Scientific vet as CEO	By Thomas Lee Apnex Medical Inc., a St. Paul, Minn.-based start-up developing technology to treat o...	massdevice...
02.06.2010	Apnex Medical names former BSX and J&J executive as its ...	Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis...	medcitynew...
10.08.2009	Domain Associates closes $500 million life science fund	Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems st...	medcitynew...
20.07.2009	Oraya scores $42M for eye radiation treatments	Oraya Therapeutics, maker of radiosurgical tools used to treat eye diseases, has brought in $42 mill...	venturebea...
16.06.2009	SkinMedica scratches up $9.4M for anti-aging pharmaceuticals	SkinMedica, maker of specialized anti-aging treatments, has raised $9.4 million in equity and rights...	venturebea...
15.04.2009	Cancer drug maker BiPar sells to Sanofi-aventis for $500M	BiPar Sciences, maker of tumor-targeting cancer treatments, will be acquired by public global pharma...	venturebea...
13.04.2009	Philanthropic fund of funds Legacy closes $276M	Legacy Venture, the Palo Alto, Calif. firm that holds a portfolio of other investment funds and dist...	venturebea...
10.04.2009	Cell Biosciences to launch new tech with $10M	Cell Biosciences announced that it’s just brought in $10 million in a third round of funding to laun...	venturebea...
09.04.2009	Investors give up on diabetes drug maker DiObex	After failing to raise a sustaining round of capital, DiObex has been effectively shut down by its i...	venturebea...
18.02.2009	Public biotech firms Cadence, Affymax draw $128M from bargai...	Much has been written about how the IPO market froze out biotech companies in 2008, but it looks lik...	venturebea...
14.01.2009	Corthera adds $10M for heart failure medication	Pharmaceutical company Corthera just took $10 million to close a $23 million third round of funding ...	venturebea...
13.01.2009	BiPar snags $20M for inhibitor-based cancer therapies	Pharmaceutical firm BiPar Sciences just brought in $20 million in private equity and venture debt to...	venturebea...
09.01.2009	Achaogen takes in $5.6M to fight bacterial infections	Pharmaceutical company Achaogen received a $5.6 million grant from the U.K.-based Wellcome Trust as ...	venturebea...
29.10.2008	BioLogix bags $6M for oncology drug, names new CEO	Biopharm company BioLogix raised $6 million in first-round equity and debt financing from Essex Wood...	venturebea...
15.05.2007	Apnex Medical raises $16.1M for sleep-apnea devices	Apnex Medical, a Minneapolis maker of implants for the treatment of obstructive sleep apnea, raised ...	venturebea...
-	Biotech company developing therapies for macular edema raise...	Alimera Sciences, a public company without any revenue, has developed a drug delivery system to be i...	medcitynew...
-	$14M round for ‘cross-kingdom vaccine’ maker will fund trial...	Whereas most vaccines under development are designed to protect against one kind of pathogen, NovaDi...	medcitynew...
-	Celator Pharmaceuticals raising $5 million for cancer treatm...	Celator Pharmaceuticals, a drug development company, is raising $5 million as its drug therapy for a...	medcitynew...
-	RightCare Solutions secures $4 million investment from NewSp...	A Philadelphia health IT company that developed a predictive analytics tool to help hospitals get a ...	medcitynew...
-	Domain Associates closes $500 million life science fund	PRINCETON, New Jersey — Venture fund Domain Associates has closed a $500 million fund to invest in e...	medcitynew...
-	Health IT company nets $5M for tool to lower readmissions	As hospitals face increased penalties for higher than average readmission rates for an expanding lis...	medcitynew...
-	Health IT tool to reduce hospital readmissions identifies vu...	A healthcare IT program aimed at reducing hospital readmissions by more effectively coordinating vul...	medcitynew...
-	A look at the underbelly of Theranos, plus 5 must-read stori...	This week on MedHeads, we talked Theranos – specifically, the fallout from the damning Wall Street J...	medcitynew...
-	Discharge decision support startup feted by Janssen raises $...	A health IT company that won a Janssen Innovation Challenge to devise ways to reduce unnecessary hos...	medcitynew...
-	Cancer diagnostics firm that can enable personalized medicin...	San Diego-based biotech firm Epic Sciences announced Tuesday that the company has raised $13 million...	medcitynew...
-	Early stage biotechs face funding gap as VCs seek surer bets...	Biotechnology companies seeking venture capital got some sobering perspective at the CED Biotech/Lif...	medcitynew...
-	Domain VC: Why we’re investing more in molecular diagnostics...	When Domain Associates led Xagenic Inc.’s recent $20 million Series B, it marked the eighth diagnost...	medcitynew...
-	Biopharma startup raises $51M for therapeutic to treat bleed...	In one of the largest financing rounds this year, biopharmaceutical startup Regado Biosciences has r...	medcitynew...
-	Watch out, Theranos? Edico Genome CEO backing stealth one-dr...	Looks like a new single-drop-of-blood startup is is in the diagnostics arena: SalveoDx, a San Diego-...	medcitynew...
-	Apnex Medical names former BSX and J&J executive as its ...	Apnex Medical Inc., a St. Paul-based startup developing technology to treat obstructive sleep apnea ...	medcitynew...
-	Benvenue Medical secures $40M Series E to beef up manufactur...	Spine tech startup Benvenue Medical has secured a $40 million Series E, plus $24 million in debt fin...	medcitynew...
-	Morning Read: Personal genetic map may soon be as cheap as a...	The same market forces that made computers cheaper and faster are influencing the cost of gene mappi...	medcitynew...
-	Healthcare startup with noninvasive, one-time wet AMD treatm...	Oraya Therapeutics, one of California’s many healthcare startups, has distinguished itself from the ...	medcitynew...
-	Cash from innovation challenges will provide pilot testing f...	A readmission risk assessment tool and two diabetes education programs will now be put to the ultima...	medcitynew...